| Original language | English (US) |
|---|---|
| Pages (from-to) | 1302-1303 |
| Number of pages | 2 |
| Journal | JAMA |
| Volume | 328 |
| Issue number | 13 |
| DOIs |
|
| State | Published - Oct 4 2022 |
| Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Telmisartan and Walking Performance in Peripheral Artery Disease. / Bonaca, Marc P.; Hess, Connie; Beckman, Joshua A.
In: JAMA, Vol. 328, No. 13, 04.10.2022, p. 1302-1303.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Telmisartan and Walking Performance in Peripheral Artery Disease
AU - Bonaca, Marc P.
AU - Hess, Connie
AU - Beckman, Joshua A.
N1 - Funding Information: Worldwide Clinical Trials, and WraSer Pharmaceuticals and receiving personal fees from Audentes Therapeutics (now Astellas Gene Therapies). Dr Hess reported receiving grants from Amgen, Bayer, and Janssen Pharmaceuticals. Dr Beckman reported receiving personal fees from JanOne Inc, Janssen Pharmaceuticals, and Novartis. Funding Information: reported receiving grants from Abbott Laboratories, Agios Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Amgen, Angionetics, ARCA Biopharma, Array BioPharma, AstraZeneca, Atentiv Health, Audentes Therapeutics (now Astellas Gene Therapies), Bayer, Better Therapeutics, Brigham and Women’s Hospital, Bristol-Myers Squibb, Cardiol Therapeutics, CellResearch Corporation, Cook Medical, CSL Behring, Eidos Therapeutics, EP Trading Co, Esperion Therapeutics, Everlywell, Faraday Pharmaceuticals, Fortress Biotech, HDL Therapeutics, HeartFlow, Hummingbird Bioscience, Insmed, Janssen Pharmaceuticals, Kowa Research Institute, Lexicon Pharmaceuticals, Merck, Medtronic, Moderna, Novate Medical, Novo Nordisk, Pfizer, PhaseBio Pharmaceuticals, Pharmaceutical Product Development (PPD Inc), Prairie Education and Research, Prothena Corp, Regeneron Pharmaceuticals, Regio Biosciences, Sanifit Therapeutics, Sanofi, Smith and Nephew, Stealth BioTherapeutics, University of Colorado,
PY - 2022/10/4
Y1 - 2022/10/4
UR - http://www.scopus.com/inward/record.url?scp=85139553248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139553248&partnerID=8YFLogxK
U2 - 10.1001/jama.2022.14912
DO - 10.1001/jama.2022.14912
M3 - Comment/debate
C2 - 36194236
AN - SCOPUS:85139553248
SN - 0098-7484
VL - 328
SP - 1302
EP - 1303
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 13
ER -